Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:NRXP 14 January 2026

NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset

NRXP stock slips premarket as NRx says FDA fast-tracked ketamine bid with 70,000-patient dataset

NRx Pharmaceuticals shares fell 4.3% to $2.13 in premarket trading after the FDA granted Fast Track status to its ketamine-based NRX-100 for suicidal ideation. The company plans to submit data from over 70,000 U.S. patients to support accelerated approval. Investors await further FDA feedback and updates during the San Francisco healthcare conference.
14 January 2026
··

Stock Market Today

  • i-80 Gold Valuation Reviewed After 30% Price Drop Amid Mixed Performance
    March 20, 2026, 9:47 AM EDT. i-80 Gold (TSX:IAU) shares have slid roughly 30% over the past month despite a 77.45% one-year total shareholder return, contrasting with a 42.17% loss over three years. The stock trades at CA$1.81, far below a projected fair value of CA$18.88 based on bullish production and profitability forecasts. However, the company faces a significant challenge turning a US$198.8 million net loss into sustainable profits. Current price-to-sales ratio of 11.8x is notably above the industry average of 6.8x, suggesting the market may have priced in high growth expectations. Investors should weigh the potential upside against execution risks and valuation concerns amid ongoing market volatility.
Go toTop